
Overview
Background
Gabrielle Belz originally trained in veterinary medicine and surgery and received her PhD in understanding the organisation of lymphatics and lymphoid tissues at The University of Queensland. After a short stint in Canada to work on B cells, she moved to St Jude Children’s Research Hospital to work with Peter Doherty supported by an NHMRC CJ Martin Fellowship. Here she established a number of systems that now allow tracking of virus-specific T cells and established the paradigm changing notion that CD4 T cell help was required for generating antiviral responses. She returned to The Walter and Eliza Hall Institute of Medical Research and uncovered the identity of the key dendritic cells necessary for initiating antiviral infections. Subsequently she was awarded the Burnet Prize and NHMRC Elizabeth Blackburn Fellowship. Her research contributions have been recognized by a number of awards including a Wellcome Trust Overseas Fellowship, HHMI international fellowship, ARC Future fellowship, Doctor of Veterinary Science, the Gottschalk Medal (Australian Academy of Science) and in 2024 an ARC Laureate Fellowship. Her laboratory focuses on deciphering the key cellular and transcriptional signals of protective immunity particularly by T cells and in understanding how innate immune cells develop and make novel contributions to mucosal immune defence.
Availability
- Professor Gabrielle Belz is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Veterinary Biology, The University of Queensland
- Bachelor (Honours) of Veterinary Science, The University of Queensland
- Doctor of Philosophy, The University of Queensland
- Doctoral Diploma, The University of Queensland
Research impacts
Overall goals:
Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites.
We are elucidating how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another.
Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.
Research interests:
Cell differentiation is the process by which cells develop and mature. In this process, cells become more specialised and acquire potent effector functions that allow them to eliminate infectious organisms. There is an urgent need to develop new therapies that focus on augmenting host immunity.
Our research focuses on:
- Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens
- How protective immunity breaks down in chronic overwhelming infections
- Identifying factors that can promote host immune responses and potent long-lived protective immunological memory.
We have developed and use a number of in vivo models of infectious diseases including:
- Influenza
- Herpes virus
- Lymphocytic choriomeningitis virus (LCMV)
These models provide us with an unprecedented opportunity to examine the mechanisms that these pathogens employ to infect hosts and elicit immune protection or to subvert the host responses. Using a variety of approaches including multiparameter flow cytometry, systems biology and global gene expression profiling we aim to define cellular and transcriptional pathways in normal memory T cell differentiation, innate immune cell subsets and immune failure.
Works
Search Professor Gabrielle Belz’s works on UQ eSpace
2021
Journal Article
Host IL11 signaling suppresses CD4+ T cell-mediated antitumor responses to colon cancer in mice
Huynh, Jennifer, Baloyan, David, Chisanga, David, Shi, Wei, O'Brien, Megan, Afshar-Sterle, Shoukat, Alorro, Mariah, Pang, Lokman, Williams, David S., Parslow, Adam C., Thilakasiri, Pathum, Eissmann, Moritz F., Boon, Louis, Masson, Frederick, Chand, Ashwini L. and Ernst, Matthias (2021). Host IL11 signaling suppresses CD4+ T cell-mediated antitumor responses to colon cancer in mice. Cancer Immunology Research, 9 (7), 735-747. doi: 10.1158/2326-6066.CIR-19-1023
2021
Journal Article
Intestinal-derived ILCs migrating in lymph increase IFNγ production in response to Salmonella Typhimurium infection
Kästele, Verena, Mayer, Johannes, Lee, Edward S., Papazian, Natalie, Cole, John J., Cerovic, Vuk, Belz, Gabrielle, Tomura, Michio, Eberl, Gerard, Goodyear, Carl, Maciewicz, Rose A., Wall, Daniel, Cupedo, Tom, Withers, David R. and Milling, Simon (2021). Intestinal-derived ILCs migrating in lymph increase IFNγ production in response to Salmonella Typhimurium infection. Mucosal Immunology, 14 (3), 717-727. doi: 10.1038/s41385-020-00366-3
2021
Conference Publication
Unleashing ILC2-dependent anti-tumor immunity to melanoma
Belz, Gabrielle T. and Jacquelot, Nicolas (2021). Unleashing ILC2-dependent anti-tumor immunity to melanoma. Immunology 2021™ Meeting, Online, 10–15 May 2021. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.206.supp.57.05
2021
Journal Article
Differences in pulmonary group 2 innate lymphoid cells are dependent on mouse age, sex and strain
Loering, Svenja, Cameron, Guy J. M., Bhatt, Nirmal P., Belz, Gabrielle T., Foster, Paul S., Hansbro, Philip M. and Starkey, Malcolm R. (2021). Differences in pulmonary group 2 innate lymphoid cells are dependent on mouse age, sex and strain. Immunology and Cell Biology, 99 (5), 542-551. doi: 10.1111/imcb.12430
2021
Journal Article
Neuroimmune interactions and rhythmic regulation of innate lymphoid cells
Jacquelot, Nicolas, Belz, Gabrielle T. and Seillet, Cyril (2021). Neuroimmune interactions and rhythmic regulation of innate lymphoid cells. Frontiers in Neuroscience, 15 657081, 1-8. doi: 10.3389/fnins.2021.657081
2021
Journal Article
Absence of Batf3 reveals a new dimension of cell state heterogeneity within conventional dendritic cells
Lukowski, Samuel W., Rodahl, Inga, Kelly, Samuel, Yu, Meihua, Gotley, James, Zhou, Chenhao, Millard, Susan, Andersen, Stacey B., Christ, Angelika N., Belz, Gabrielle, Frazer, Ian H. and Chandra, Janin (2021). Absence of Batf3 reveals a new dimension of cell state heterogeneity within conventional dendritic cells. iScience, 24 (5) 102402, 1-21. doi: 10.1016/j.isci.2021.102402
2021
Journal Article
Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies
Jacquelot, N., Tellier, J., Nutt, S.l. and Belz, G.T. (2021). Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies. OncoImmunology, 10 (1) 1900508, 1900508. doi: 10.1080/2162402x.2021.1900508
2021
Journal Article
Type 2 innate lymphoid cells protect against colorectal cancer progression and predict improved patient survival
Huang, Qiutong, Jacquelot, Nicolas, Preaudet, Adele, Hediyeh-zadeh, Soroor, Souza-Fonseca-Guimaraes, Fernando, McKenzie, Andrew N. J., Hansbro, Philip M., Davis, Melissa J., Mielke, Lisa A., Putoczki, Tracy L. and Belz, Gabrielle T. (2021). Type 2 innate lymphoid cells protect against colorectal cancer progression and predict improved patient survival. Cancers, 13 (3) 559, 559-16. doi: 10.3390/cancers13030559
2021
Journal Article
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
Jacquelot, Nicolas, Seillet, Cyril, Wang, Minyu, Pizzolla, Angela, Liao, Yang, Hediyeh-zadeh, Soroor, Grisaru-Tal, Sharon, Louis, Cynthia, Huang, Qiutong, Schreuder, Jaring, Souza-Fonseca-Guimaraes, Fernando, de Graaf, Carolyn A., Thia, Kevin, Macdonald, Sean, Camilleri, Mary, Luong, Kylie, Zhang, Shengbo, Chopin, Michael, Molden-Hauer, Tristan, Nutt, Stephen L., Umansky, Viktor, Ciric, Bogoljub, Groom, Joanna R., Foster, Paul S., Hansbro, Philip M., McKenzie, Andrew N. J., Gray, Daniel H. D., Behren, Andreas, Cebon, Jonathan ... Belz, Gabrielle T. (2021). Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma. Nature Immunology, 22 (7), 851-864. doi: 10.1038/s41590-021-00943-z
2021
Journal Article
T-helper 22 cells develop as a distinct lineage from Th17 cells during bacterial infection and phenotypic stability is regulated by T-bet
Barnes, Jessica L., Plank, Maximilian W., Asquith, Kelly, Maltby, Steven, Sabino, Lorena R., Kaiko, Gerard E., Lochrin, Alyssa, Horvat, Jay C., Mayall, Jemma R., Kim, Richard Y., Hansbro, Philip M., Keely, Simon, Belz, Gabrielle T., Tay, Hock L. and Foster, Paul S. (2021). T-helper 22 cells develop as a distinct lineage from Th17 cells during bacterial infection and phenotypic stability is regulated by T-bet. Mucosal Immunology, 14 (5), 1077-1087. doi: 10.1038/s41385-021-00414-6
2021
Journal Article
Type 2 innate lymphoid cells: a novel actor in anti-melanoma immunity
Jacquelot, Nicolas and Belz, Gabrielle T. (2021). Type 2 innate lymphoid cells: a novel actor in anti-melanoma immunity. OncoImmunology, 10 (1) 1943168, 1943168. doi: 10.1080/2162402x.2021.1943168
2020
Journal Article
Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment
Kobayashi, Takumi, Lam, Pui Yeng, Jiang, Hui, Bednarska, Karolina, Gloury, Renee Elyse, Murigneux, Valentine, Tay, Joshua, Jacquelot, Nicolas, Li, Rui, Tuong, Zewen Kelvin, Leggatt, Graham, Gandhi, Maher K., Hill, Michelle M, Belz, Gabrielle T., Ngo, Shyuan, Kallies, Axel and Mattarollo, Stephen R. (2020). Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment. Blood, 136 (26), 3004-3017. doi: 10.1182/blood.2020005602
2020
Other Outputs
Spatial Profiling of Lung SARS-CoV-2 and Influenza Virus Infection Dissects Virus-Specific Host Responses and Gene Signatures
Kulasinghe, Arutha, Tan, Chin Wee, dos Santos Miggiolaro, Anna Flavia Ribeiro, Monkman, James, Bhuva, Dharmesh, da Silva Motta, Jarbas, de Paula, Caroline Busatta Vaz, Nagashima, Seigo, Baena, Cristina Pellegrino, Souza-Fonseca-Guimaraes, Paulo, de Noronha, Lucia, McCulloch, Timothy, Rossi, Gustavo Rodrigues, Cooper, Caroline, Tang, Benjamin, Short, Kirsty R., Davis, Melissa J, Souza-Fonseca-Guimaraes, Fernando, Belz, Gabrielle T. and O’Byrne, Ken (2020). Spatial Profiling of Lung SARS-CoV-2 and Influenza Virus Infection Dissects Virus-Specific Host Responses and Gene Signatures. doi: 10.1101/2020.11.04.20225557
2020
Other Outputs
Differences in pulmonary innate lymphoid cells are dependent on mouse age, sex and strain
Loering, Svenja, Cameron, Guy J. M, Bhatt, Nirmal P, Belz, Gabrielle T, Foster, Paul S, Hansbro, Philip M and Starkey, Malcolm R (2020). Differences in pulmonary innate lymphoid cells are dependent on mouse age, sex and strain. doi: 10.1101/2020.10.25.354464
2020
Journal Article
Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders
Alemao, Charlotte A., Budden, Kurtis F., Gomez, Henry M., Rehman, Saima F., Marshall, Jacqueline E., Shukla, Shakti D., Donovan, Chantal, Forster, Samuel C., Yang, Ian A., Keely, Simon, Mann, Elizabeth R., El Omar, Emad M., Belz, Gabrielle T. and Hansbro, Philip M. (2020). Impact of diet and the bacterial microbiome on the mucous barrier and immune disorders. Allergy, 76 (3) all.14548, 1-21. doi: 10.1111/all.14548
2020
Journal Article
Systemic administration of IL‐33 induces a population of circulating KLRG1 hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma
Guillerey, Camille, Stannard, Kimberley, Chen, Jason, Krumeich, Sophie, Miles, Kim, Nakamura, Kyohei, Smith, Jessica, Yu, Yuan, Ng, Susanna, Harjunpää, Heidi, Teng, Michele W. L., Engwerda, Christian, Belz, Gabrielle T. and Smyth, Mark J. (2020). Systemic administration of IL‐33 induces a population of circulating KLRG1 hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma. Immunology and Cell Biology, 99 (1) imcb.12390, 65-83. doi: 10.1111/imcb.12390
2020
Journal Article
Tissue-resident lymphocytes: weaponized sentinels at barrier surfaces
Belz, Gabrielle T., Denman, Renae, Seillet, Cyril and Jacquelot, Nicolas (2020). Tissue-resident lymphocytes: weaponized sentinels at barrier surfaces. F1000Research, 9 691, 691. doi: 10.12688/f1000research.25234.1
2020
Journal Article
A divergent transcriptional landscape underpins the development and functional branching of MAIT cells
Koay, Hui Fern, Su, Shian, Amann-Zalcenstein, Daniela, Daley, Stephen R, Comerford, Iain, Whyte, Carly E, Konstantinov, Igor E, d’Udekem, Yves, Baldwin, Tracey, Hickey, Peter F, Berzins, Stuart P, Mak, Jeffrey Y.W., Kallies, Axel, Chen, Zhenjun, Nussing, Simone, Kedzierska, Katherine, Mackay, Laura K, McColl, Shaun R, Deenick, Elissa K, Fairlie, David P, McCluskey, James, Goodnow, Christopher C, Ritchie, Matthew E, Belz, Gabrielle T, Naik, Shalin H, Pellicci, Daniel G and Godfrey, Dale I (2020). A divergent transcriptional landscape underpins the development and functional branching of MAIT cells. The Journal of Immunology, 204 (1_Supplement), 223.8-223.8. doi: 10.4049/jimmunol.204.supp.223.8
2020
Conference Publication
Neuropeptide coordination of mucosal immunity by regulating ILC3 activity
Belz, Gabrielle T. (2020). Neuropeptide coordination of mucosal immunity by regulating ILC3 activity. Immunology 2020™ Meeting, Honolulu, HI United States, 8 - 12 May 2020. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.204.supp.148.4
2020
Journal Article
Elucidating specificity opens a window to the complexity of both the innate and adaptive immune systems
Belz, Gabrielle T. (2020). Elucidating specificity opens a window to the complexity of both the innate and adaptive immune systems. Viral Immunology, 33 (3), 145-152. doi: 10.1089/vim.2019.0186
Funding
Current funding
Supervision
Availability
- Professor Gabrielle Belz is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
Understanding mucosal immunity
The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.
-
Delineating long-term protective immunity to pathogen infection
Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.
Our research focuses on:
- Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
- How protective immunity breaks down in chronic overwhelming infections
- Identifying factors that can promote host immune responses and potent long-lived protective immunological memory
-
Understanding mucosal immunity
The picture of the network governing the mucosal immunity and how the different immune populations interplay is only just emerging, but it is already opening a whole new array of exciting possibilities for immune regulation and immunotherapeutic strategies. Our current projects aim to provide a new dimension to this emerging field in understanding how mucosal epithelial cells interact with immune cells to drive mucosal immunosurveillance, homeostasis and immunity. We have developed a number of new tools to dissect this epithelial immune network and understand its regulation in immunity.
-
Delineating long-term protective immunity to pathogen infection
Our work aims to understand how the immune system responds to infections including viruses, bacteria and parasites. We endeavour to elucidate how different types of immune cells develop, and what factors influences their decision to become one type of immune cell or another. Understanding how the body deals with pathogens will give clues about how to enhance protective immunity. Our goal is to discover new therapies that boost our immune system to protect against infection.
Our research focuses on:
- Elucidating the mechanisms responsible for the generation of protective immunity in response to lung and gastrointestinal pathogens including influenza, herpesvirus and intestinal bacterial infections
- How protective immunity breaks down in chronic overwhelming infections
- Identifying factors that can promote host immune responses and potent long-lived protective immunological memory
-
Unravelling immune signalling networks in mucosal immunity
Mucosal surfaces are critical interfaces where host-environment interactions occur, and the interplay between epithelial cells and immune components is essential for balancing tolerance and immunity. Disruptions to mucosal barrier integrity have profound consequences, contributing to the onset and progression of numerous diseases. Moreover, mucosal surfaces are key entry points for pathogens, including emerging viral threats, making a robust barrier indispensable for preventing infection. Despite the importance of this barrier, our understanding of how it is regulated and integrates signals from the microbiome to the immune cells is poorly understood.
This exciting opportunity aims to unravel the intricate interactions between immune cells and epithelial tissues, with a focus on understanding their roles in maintaining barrier integrity and immune homeostasis in mucosal environments such as the gut, lungs, and skin. This project will investigate how epithelial cells communicate with innate and adaptive immune cells to modulate responses to microbial, dietary, and environmental stimuli.
Utilizing cutting-edge approaches including advanced imaging, organoid co-culture systems, multiomics, and animal models, the candidate will uncover molecular mechanisms that underpin immune-epithelial cross-talk. The findings will unravel new knowledge that sets the foundation for the development of new strategies for diseases such as inflammatory bowel disease, asthma, and other epithelial barrier disorders.
The Belz Laboratory
The successful candidate will join a dynamic and interdisciplinary research team in a supportive academic environment. Our team is composed of highly collaborative passionate post-doctoral scientists, research assistants and PhD students with diverse backgrounds. We have expertise in state-of the art imaging, multi-dimensional flow cytometry and mucosal immunology. We provide a unique, collaborative environment and opportunity to develop diverse skill-sets and make impactful discoveries.
Frazer Institute at the University of Queensland
The Frazer Institute at the University of Queensland offers a dynamic and collaborative research environment dedicated to advancing biomedical innovation. Situated in Brisbane, a vibrant and rapidly growing hub for science and technology, the Institute provides access to world-class facilities and resources in a stunning subtropical setting.
As a leading research centre, the Frazer Institute fosters interdisciplinary collaboration, bringing together experts in immunology, molecular biology, and translational medicine. Its strategic partnerships with hospitals, biotech industries, and global research networks enable researchers to translate discoveries into real-world applications.
The Institute is equipped with state-of-the-art technologies, including single-cell genomics, high-resolution imaging, organoid platforms, and advanced proteomics. These cutting-edge tools empower researchers to explore complex biological questions with unprecedented precision.
With its emphasis on mentorship, innovation, and impact-driven research, the Frazer Institute offers exceptional opportunities for scientists aiming to contribute to transformative discoveries in health and medicine.
The Frazer Institute is committed to diversity and equal opportunity and the development of emerging researchers at the highest level.
Supervision history
Current supervision
-
Doctor Philosophy
Immune Regulation of Lung Injury: Pathways to Repair, Restoration and Fibrosis
Principal Advisor
Other advisors: Professor Dan Chambers
-
Doctor Philosophy
Understanding development of an mRNA vaccine to prevent Group A Streptococcus pharyngeal infection
Principal Advisor
Other advisors: Professor Mark Walker
-
Doctor Philosophy
Studying the tumour immune microenvironment in cutaneous squamous cell carcinoma
Principal Advisor
Other advisors: Associate Professor Arutha Kulasinghe
-
Doctor Philosophy
Understanding Key Epithelial Cells Following Lung Infection
Principal Advisor
Other advisors: Associate Professor Fernando Guimaraes
-
Doctor Philosophy
Understanding Key Epithelial Cells Following Lung Infection
Principal Advisor
Other advisors: Associate Professor Fernando Guimaraes
-
Doctor Philosophy
Deciphering the protective program of innate and adaptive cells in pathogen infection
Principal Advisor
Other advisors: Associate Professor Timothy Wells
-
Doctor Philosophy
High Mobility Group Box Family Member TOX2 in Innate Lymphoid Cell Development and Maintenance
Principal Advisor
Other advisors: Associate Professor Timothy Wells
-
Doctor Philosophy
The role of innate cells in shaping the tumour environment.
Principal Advisor
Other advisors: Associate Professor Fernando Guimaraes, Dr M. Zeeshan Chaudhry
-
Doctor Philosophy
Understanding development of an mRNA vaccine to prevent Group A Streptococcus pharyngeal infection
Principal Advisor
Other advisors: Professor Mark Walker
-
Doctor Philosophy
Innate lymphoid cells in tumour control
Principal Advisor
-
Doctor Philosophy
Understanding immune diversity in skin inflammation
Associate Advisor
Other advisors: Professor Kiarash Khosrotehrani, Dr Snehlata Kumari
-
Doctor Philosophy
The Ins and Outs of Endocytosis inhibition: Providing diverse opportunities for treatment of incurable cancers
Associate Advisor
Other advisors: Dr Shannon Joseph, Professor Fiona Simpson
-
Doctor Philosophy
Preclinical refinement of a UQ-Moderna vaccine developed to prevent StrepA infection
Associate Advisor
Other advisors: Dr Nichaela Harbison-Price, Professor Mark Walker
-
Doctor Philosophy
Development of natural killer cells with enhanced tumoricidal functions using CRISPR homology-directed repair-mediated gene editing
Associate Advisor
Other advisors: Dr Allie Lam, Associate Professor Fernando Guimaraes
Completed supervision
Media
Enquiries
For media enquiries about Professor Gabrielle Belz's areas of expertise, story ideas and help finding experts, contact our Media team: